Sermorelin
Sermorelin is a synthetic version of the first 29 amino acids of growth-hormone-releasing hormone.
The short version
- Why people discuss it
- Discussed for sleep, growth-hormone support, recovery and body composition. Adult wellness use is distinct from its historical pediatric and diagnostic indications; community interest does not establish clinical benefit.
- What it is
- Sermorelin is a synthetic version of the first 29 amino acids of growth-hormone-releasing hormone.
- Biggest caution
- Historical product evidence, compounded preparations and products sold under the same name may differ. Hormone-release measurements do not establish anti-aging, recovery or body-composition benefits.
- Stack context
- Related profiles reflect adjacent community topics or biological context. They do not establish combination benefit, compatibility or a validated regimen.
Dose and frequency reference
Reference only — not a recommendation. Amounts describe source-specific community examples, selected study regimens or the named product label. They do not establish safety, effectiveness, product identity, or a suitable dose for any person. Never convert mg, mcg, or IU into syringe “units” without the exact product concentration.
Source agreement describes reported practice, not clinical validation.
Subcutaneous injection
Community reference · Not clinical guidance- Amount
- 200–300 mcg
- Frequency
- At bedtime, 5–7 nights weekly
- Duration / phase
- 3–6 months
Repeated adult community convention; 300–500 mcg appears as a higher-end variant. The historical pediatric label does not validate adult wellness dosing. Reference only; this does not establish safety, effectiveness or individual suitability.
Community source · reviewed 2026-09-27Compare reported schedules
Saved source material reviewed 2026-09-27. Multiple pages from one publisher count as one source family; agreement does not establish what most people use. SC means subcutaneous; IM intramuscular; IP intraperitoneal.
- PeptideDosages — saved source reviewed September 27, 2026
200→500 mcg SC nightly, 3–6 months.
- Peptidepedia — saved source reviewed September 27, 2026
200–300 mcg SC at bedtime 5–7 nights/week; higher 300–500 mcg; review at 3–6 months.
Evidence & sources · Community source profile
AxonRep synthesizes community discussion signals from its internal research corpus. Individual creator sources remain attributed to the synthesis; public reference sites used in the latest comparison are linked separately. The synthesis is not clinical evidence.
- AxonRep community research synthesisAxonRep synthesis · Checked 2026-09-12
- PeptideDosages — saved source reviewed September 27, 2026Community reference · Checked 2026-09-27
- Peptidepedia — saved source reviewed September 27, 2026Community reference · Checked 2026-09-27